AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 59 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $46,000 | -78.7% | 36,000 | -62.5% | 0.03% | -79.7% |
| Q1 2016 | $216,000 | -35.7% | 96,000 | 0.0% | 0.13% | -37.9% |
| Q4 2015 | $336,000 | +21.3% | 96,000 | 0.0% | 0.21% | +15.1% |
| Q3 2015 | $277,000 | +21.5% | 96,000 | 0.0% | 0.19% | +42.0% |
| Q2 2015 | $228,000 | -68.5% | 96,000 | 0.0% | 0.13% | -68.9% |
| Q1 2015 | $723,000 | +177.0% | 96,000 | +26.3% | 0.42% | +180.7% |
| Q4 2014 | $261,000 | -4.0% | 76,000 | -1.3% | 0.15% | -5.1% |
| Q3 2014 | $272,000 | -41.3% | 77,000 | +38.7% | 0.16% | -47.0% |
| Q2 2014 | $463,000 | +32.7% | 55,500 | +0.9% | 0.30% | +26.8% |
| Q1 2014 | $349,000 | -9.4% | 55,000 | +1.9% | 0.24% | -5.2% |
| Q4 2013 | $385,000 | +4.6% | 54,000 | +10.2% | 0.25% | -8.1% |
| Q3 2013 | $368,000 | +73.6% | 49,000 | +33.5% | 0.27% | +67.7% |
| Q2 2013 | $212,000 | – | 36,700 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
| CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
| Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
| Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
| COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
| NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
| Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |